ID :
19281
Fri, 09/12/2008 - 21:32
Auther :
Shortlink :
https://www.oananews.org//node/19281
The shortlink copeid
MRCCC TO BE FIRST CANCER CENTER USING VARIAN LINEAR ACCELERATORS
Jakarta, Sept 12 (ANTARA) - The Mochtar Riady Comprehensive Cancer Center (MRCCC) will be the first cancer treatment center in Indonesia to use the newest radiotherapy equipment called linear accelerators (linacs) produced by US Varian Medical Systems.
"The equipment will help doctors conduct image-guided therapy on patients," Siloam Hospital Chief Operating Medical Officer Dr Grace Frelita said at the signing of a memorandum of understanding between the MRCCC and the Varian Medical Systems here on Friday.
"The equipment will be helpful in treating cancer patients in Indonesia now numbering around 800,000 a year," she said.
The signing was attended by three members of PT Lippo Karawaci Tbk's board of commissioners namely Eddy Sindoro, Farid Harianto and Surjadi Soedirdja, president of the Mochtar Riady Institute for Nanotechnology (MRIN), Prof. Susan Tai and chief executive office of Varian Medical Systems Timothy Guertin.
The MRCC, MRIN and Siloam Hospital belong to Lippo Group.
"The MRCCC will be the first cancer treatment in Indonesia to use the newest equipment which costs between US$1 million to US$3 million per unit. The MRCCC plans to buy three units," Timothy said.
He said Varian linacs creates a high energy x-ray that could destroy tumor by damaging its cancer cells so that they will not be able to recover.
He said its work system is different from the conventional therapy known for treating cancer so far.
With its high degree of accuracy the Varian linacs could detect correctly the location of the disease so that its ray would be concentrated on the tumor and would not damage healthy tissues surrounding it.
The MRCCC project and the development of cancer center building to be named "Building of Hope" have been started since May 12 2007 with an investment of around US$100 million.
The projects are now still underway and is expected to finish and start operating in December 2009.
The MRCCC will be part of the Building of Hope which stands on a 53,000 square meter plot of land on Jalan Garnisum Dalam in Jakarta and will have 29 stories and 210 beds.
"The equipment will help doctors conduct image-guided therapy on patients," Siloam Hospital Chief Operating Medical Officer Dr Grace Frelita said at the signing of a memorandum of understanding between the MRCCC and the Varian Medical Systems here on Friday.
"The equipment will be helpful in treating cancer patients in Indonesia now numbering around 800,000 a year," she said.
The signing was attended by three members of PT Lippo Karawaci Tbk's board of commissioners namely Eddy Sindoro, Farid Harianto and Surjadi Soedirdja, president of the Mochtar Riady Institute for Nanotechnology (MRIN), Prof. Susan Tai and chief executive office of Varian Medical Systems Timothy Guertin.
The MRCC, MRIN and Siloam Hospital belong to Lippo Group.
"The MRCCC will be the first cancer treatment in Indonesia to use the newest equipment which costs between US$1 million to US$3 million per unit. The MRCCC plans to buy three units," Timothy said.
He said Varian linacs creates a high energy x-ray that could destroy tumor by damaging its cancer cells so that they will not be able to recover.
He said its work system is different from the conventional therapy known for treating cancer so far.
With its high degree of accuracy the Varian linacs could detect correctly the location of the disease so that its ray would be concentrated on the tumor and would not damage healthy tissues surrounding it.
The MRCCC project and the development of cancer center building to be named "Building of Hope" have been started since May 12 2007 with an investment of around US$100 million.
The projects are now still underway and is expected to finish and start operating in December 2009.
The MRCCC will be part of the Building of Hope which stands on a 53,000 square meter plot of land on Jalan Garnisum Dalam in Jakarta and will have 29 stories and 210 beds.